Impact of Lipids on Cardiovascular Health

2013 ACCF/AHA Guideline for the Management of Heart Failure

Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536 · see citing works

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)

Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490 · see citing works

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · see citing works

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550 · see citing works

2016 European Guidelines on cardiovascular disease prevention in clinical practice

Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457 · see citing works

A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure

Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981 · see citing works

Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association

Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797 · see citing works

Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R., Simons-Morton, D. G., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440101 · Cited by 5,638 · see citing works

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290 · see citing works

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

Goff, D. C., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., Greenland, P., Lackland, D. T., Levy, D., O’Donnell, C. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.005 · Cited by 4,945 · see citing works

Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association’s Strategic Impact Goal Through 2020 and Beyond

Lloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750 · see citing works

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

Lawlor, D. A., Harbord, R. M., Sterne, J. A. C., Timpson, N., & Davey Smith, G. (2008) · Statistics in Medicine · doi:10.1002/sim.3034 · Cited by 4,618 · see citing works

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962 · see citing works

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.002 · Cited by 3,845 · see citing works

Biological, clinical and population relevance of 95 loci for blood lipids

Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., et al. (2010) · Nature · doi:10.1038/nature09270 · Cited by 3,527 · see citing works

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works

Untitled work

Willer (2013) · doi:10.1038/ng.2797 · Cited by 2,983 · see citing works

2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261 · see citing works

Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial

Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047 · see citing works

Interpretation of the evidence for the efficacy and safety of statin therapy

Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857 · see citing works

Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score

Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814 · see citing works

Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis

Silverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016) · JAMA · doi:10.1001/jama.2016.13985 · Cited by 1,483 · see citing works

Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications

Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399 · see citing works

A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins

Goldstein, J. L., & Brown, M. S. (2015) · Cell · doi:10.1016/j.cell.2015.01.036 · Cited by 1,233 · see citing works

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

Nicholls, S. J., Puri, R., Anderson, T., Ballantyne, C. M., Cho, L., Kastelein, J. J. P., Koenig, W., Somaratne, R., Kassahun, H., Yang, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.16951 · Cited by 1,178 · see citing works

2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult

Anderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.510 · Cited by 1,173 · see citing works

Effects of Protein, Monounsaturated Fat, and Carbohydrate Intake on Blood Pressure and Serum Lipids: Results of the OmniHeart Randomized Trial

Appel, L. J., Sacks, F. M., Carey, V. J., Obarzanek, E., Swain, J. F., Miller, E. R., Conlin, P. R., Erlinger, T. P., Rosner, B. A., Laranjo, N. M., et al. (2005) · JAMA · doi:10.1001/jama.294.19.2455 · Cited by 1,170 · see citing works

2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk

Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160 · see citing works

Prevalence and Extent of Atherosclerosis in Adolescents and Young Adults Implications for Prevention From the Pathobiological Determinants of Atherosclerosis in Youth Study

Strong, J. P. (1999) · JAMA · doi:10.1001/jama.281.8.727 · Cited by 1,001 · see citing works

Lifetime risks of cardiovascular disease

Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1012848 · Cited by 945 · see citing works

Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease

Ference, B. A., Yoo, W., Alesh, I., Mahajan, N., Mirowska, K. K., Mewada, A., Kahn, J., Afonso, L., Williams, K. A., & Flack, J. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.017 · Cited by 898 · see citing works

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

Nicholls, S. J., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R. M., Libby, P., Raichlen, J. S., Uno, K., Borgman, M., Wolski, K., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1110874 · Cited by 896 · see citing works

Variation in<i>PCSK9</i>and<i>HMGCR</i>and Risk of Cardiovascular Disease and Diabetes

Ference, B. A., Robinson, J. G., Brook, R. D., Catapano, A. L., Chapman, M. J., Neff, D. R., Voros, S., Giugliano, R. P., Davey Smith, G., Fazio, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604304 · Cited by 743 · see citing works

High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults

Tuzcu, E. M., Kapadia, S. R., Tutar, E., Ziada, K. M., Hobbs, R. E., McCarthy, P. M., Young, J. B., & Nissen, S. E. (2001) · Circulation · doi:10.1161/01.cir.103.22.2705 · Cited by 673 · see citing works

Coronary Artery Disease in Combat Casualties in Vietnam

McNamara, J. (1971) · JAMA · doi:10.1001/jama.1971.03180330061012 · Cited by 607 · see citing works

Optimal low-density lipoprotein is 50 to 70 mg/dl

O’Keefe, J. H., Cordain, L., Harris, W. H., Moe, R. M., & Vogel, R. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.046 · Cited by 476 · see citing works

Recommended Dietary Pattern to Achieve Adherence to the American Heart Association/American College of Cardiology (AHA/ACC) Guidelines: A Scientific Statement From the American Heart Association

Horn, L. V., Carson, J. A. S., Appel, L. J., Burke, L. E., Economos, C. D., Karmally, W., Lancaster, K. J., Lichtenstein, A. H., Johnson, R. K., Thomas, R. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000462 · Cited by 431 · see citing works

Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both

Ference, B. A., Majeed, F., Penumetcha, R., Flack, J. M., & Brook, R. D. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.020 · Cited by 407 · see citing works

Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors

Fernández-Friera, L., Fuster, V., López-Melgar, B., Oliva, B., García-Ruiz, J. M., Mendiguren, J., Bueno, H., Pocock, S., Ibáñez, B., Fernández-Ortiz, A., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.024 · Cited by 378 · see citing works

Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study

Kaplan, H., Thompson, R. C., Trumble, B. C., Wann, L. S., Allam, A. H., Beheim, B., Frohlich, B., Sutherland, M. L., Sutherland, J. D., Stieglitz, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30752-3 · Cited by 338 · see citing works

Association of genetic variants related to CETP inhibitors and statins with lipoprotein levels and cardiovascular risk

Ference, B. A., Kastelein, J. J. P., Ginsberg, H. N., Chapman, M. J., Nicholls, S. J., Ray, K. K., Packard, C. J., Laufs, U., Brook, R. D., Oliver-Williams, C., et al. (2017) · JAMA · doi:10.1001/jama.2017.11467 · Cited by 304 · see citing works

Trends in Lipids and Lipoproteins in US Adults, 1988-2010

Carroll, M. D., Kit, B. K., Lacher, D. A., Shero, S. T., & Mussolino, M. E. (2012) · JAMA · doi:10.1001/jama.2012.13260 · Cited by 282 · see citing works

Nature's randomised trials

Hingorani, A. D., & Humphries, S. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67767-7 · Cited by 277 · see citing works

Effect of a Dietary Portfolio of Cholesterol-Lowering Foods Given at 2 Levels of Intensity of Dietary Advice on Serum Lipids in Hyperlipidemia: A Randomized Controlled Trial

Jenkins, D. J. A., Jones, P. J. H., Lamarche, B., Kendall, C. W. C., Faulkner, D., Cermakova, L., Gigleux, I., Ramprasath, V., de Souza, R., Ireland, C., et al. (2011) · JAMA · doi:10.1001/jama.2011.1202 · Cited by 218 · see citing works

Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool: A Special Report From the American Heart Association and American College of Cardiology

Lloyd‐Jones, D. M., Huffman, M. D., Karmali, K. N., Sanghavi, D. M., Wright, J. S., Pelser, C. B., Gulati, M., Masoudi, F. A., & Goff, D. C. (2016) · Circulation · doi:10.1161/cir.0000000000000467 · Cited by 165 · see citing works

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration

Ference, B. A., Cannon, C. P., Landmesser, U., Lüscher, T. F., Catapano, A. L., & Ray, K. K. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx450 · Cited by 161 · see citing works

Trends in Serum Lipids Among US Youths Aged 6 to 19 Years, 1988-2010

Kit, B. K., Carroll, M. D., Lacher, D. A., Sorlie, P. D., DeJesus, J. M., & Ogden, C. (2012) · JAMA · doi:10.1001/jama.2012.9136 · Cited by 134 · see citing works

Tsimané: Das gesündeste Volk der Welt

(2017) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0043-106661 · Cited by 127 · see citing works

Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology

Graham, I. M., Stewart, M., Hertog, M. G. L., & Forced, O. B. O. T. C. R. T. T. (2006) · European Journal of Cardiovascular Prevention &amp; Rehabilitation · doi:10.1097/01.hjr.0000219112.02544.24 · Cited by 116 · see citing works

The SI! Program for Cardiovascular Health Promotion in Early Childhood

Peñalvo, J. L., Santos-Beneit, G., Sotos‐Prieto, M., Bodega, P., Oliva, B., Orrit, X., Rodríguez, C., Fernández-Alvira, J. M., Redondo, J., Vedanthan, R., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.014 · Cited by 111 · see citing works

How to use Mendelian randomization to anticipate the results of randomized trials

Ference, B. A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx462 · Cited by 96 · see citing works

Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

Lloyd‐Jones, D. M., Huffman, M. D., Karmali, K. N., Sanghavi, D. M., Wright, J. S., Pelser, C. B., Gulati, M., Masoudi, F. A., & Goff, D. C. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.018 · Cited by 96 · see citing works

Mendelian randomization studies

Ference, B. A. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000247 · Cited by 82 · see citing works

Lipoprotein concentrations in newborns are associated with allelic variations in their mothers

Descamps, O. S., Bruniaux, M., Guilmot, P.-F., Tonglet, R., & Heller, F. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.002 · Cited by 46 · see citing works

The Role of Early LDL Lowering to Prevent the Onset of Atherosclerotic Disease

Ference, B. A., & Mahajan, N. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0312-1 · Cited by 40 · see citing works

Promoción de la salud cardiovascular en tres etapas de la vida: nunca es demasiado pronto, nunca demasiado tarde

Castellano, J. M., Peñalvo, J. L., Bansilal, S., & Fuster, V. (2014) · Revista Española de Cardiología · doi:10.1016/j.recesp.2014.03.012 · Cited by 39 · see citing works

New metrics needed to visualize the long-term impact of early LDL-C lowering on the cardiovascular disease trajectory

Packard, C. J., Weintraub, W. S., & Laufs, U. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.03.008 · Cited by 27 · see citing works

A Common KIF6 Polymorphism Increases Vulnerability to Low-Density Lipoprotein Cholesterol: Two Meta-Analyses and a Meta-Regression Analysis

Ference, B. A., Yoo, W., Flack, J. M., & Clarke, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028834 · Cited by 25 · see citing works

Promotion of Cardiovascular Health at Three Stages of Life: Never Too Soon, Never Too Late

Castellano, J. M., Peñalvo, J. L., Bansilal, S., & Fuster, V. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2014.03.012 · Cited by 23 · see citing works

Improvement in the estimation of cardiovascular risk by carotid intima-medial thickness: A report from the Dublin Cardiohealth station study

Cooney, M., Cooney, M. T., Maher, V. M. G., Khan, B., Leong, T., & Graham, I. M. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.08.004 · Cited by 11 · see citing works

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854 · see citing works

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536 · see citing works

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896 · see citing works

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601 · see citing works

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.009 · Cited by 1,193 · see citing works

Untitled work

(2019) · doi:10.1161/cir.0000000000000677 · Cited by 4,501 · see citing works

Time Course of LDL Cholesterol Exposure and Cardiovascular Disease Event Risk

Domanski, M. J., Tian, X., Wu, C. O., Reis, J. P., Dey, A. K., Gu, Y., Zhao, L., Bae, S., Liu, K., Hasan, A. A., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.059 · Cited by 411 · see citing works

Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis

Ye, Z., Hu, T., Wang, J., Xiao, R., Liao, X., Liu, M., & Sun, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.933913 · Cited by 326 · see citing works

Association Between Cumulative Low-Density Lipoprotein Cholesterol Exposure During Young Adulthood and Middle Age and Risk of Cardiovascular Events

Zhang, Y., Pletcher, M. J., Vittinghoff, E., Clemons, A. M., Jacobs, D. R., Allen, N. B., Alonso, A., Bellows, B. K., Oelsner, E. C., Zeki Al Hazzouri, A., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.3508 · Cited by 257 · see citing works

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

Roeters van Lennep, J. E., Tokgözoğlu, L. S., Badimon, L., Dumanski, S. M., Gulati, M., Hess, C. N., Holven, K. B., Kavousi, M., Kayıkçıoğlu, M., Lutgens, E., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad472 · Cited by 229 · see citing works

The Role of Gut Microbiota on Cholesterol Metabolism in Atherosclerosis

Vourakis, M., Mayer, G., & Rousseau, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158074 · Cited by 219 · see citing works

Side effects of statins: from pathophysiology and epidemiology to diagnostic and therapeutic implications

Ruscica, M., Ferri, N., Banach, M., Sirtori, C. R., & Corsini, A. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac020 · Cited by 208 · see citing works

Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants

Wang, N., Fulcher, J., Abeysuriya, N., Park, L., Kumar, S., Di Tanna, G. L., Wilcox, I., Keech, A., Rodgers, A., & Lal, S. (2020) · The Lancet Diabetes &amp; Endocrinology · doi:10.1016/s2213-8587(19)30388-2 · Cited by 187 · see citing works

The LDL cumulative exposure hypothesis: evidence and practical applications

Ference, B. A., D, E. B. M., & Catapano, A. L. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01039-5 · Cited by 191 · see citing works

Sex differences in lipids: a life course approach

Holven, K. B., & Roeters van Lennep, J. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117270 · Cited by 180 · see citing works

Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu)

Tian, K., Li, J., & Xu, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.019 · Cited by 178 · see citing works

Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy

Vinci, P., Panizon, E., Tosoni, L. M., Cerrato, C., Pellicori, F., Mearelli, F., Biasinutto, C., Fiotti, N., Girolamo, F. G. D., & Biolo, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111687 · Cited by 180 · see citing works

Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial

Ray, K. K., Stoekenbroek, R. M., Kallend, D., Nishikido, T., Leiter, L. A., Landmesser, U., Wright, R. S., Wijngaard, P. L. J., & Kastelein, J. J. P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3502 · Cited by 172 · see citing works

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society

Kronenberg, F., Mora, S., Stroes, E. S. G., Ference, B. A., Arsenault, B. J., Berglund, L., Dweck, M. R., Koschinsky, M. L., Lambert, G. C., Mach, F., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.04.012 · Cited by 142 · see citing works

Public health guidelines should recommend reducing saturated fat consumption as much as possible: YES

Kris‐Etherton, P. M., & Krauss, R. M. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa110 · Cited by 134 · see citing works

PCSK9 inhibition and inflammation: A narrative review

Ruscica, M., Tokgözoğlu, L. S., Corsini, A., & Sirtori, C. R. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.07.015 · Cited by 130 · see citing works

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works

There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness

Makover, M. E., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100371 · Cited by 133 · see citing works

Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

Mendieta, G., Pocock, S., Mass, V., Moreno, A. D., Owen, R., García‐Lunar, I., López‐Melgar, B., Fuster, J. J., Andrés, V., Pérez-Herreras, C., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.814 · Cited by 116 · see citing works

Chinese Guideline on the Primary Prevention of Cardiovascular Diseases

Chinese Society of Cardiology of Chinese Medical Association, C. D. P. A. R. C. O. C. A. O. R. M. (2021) · Cardiology Discovery · doi:10.1097/cd9.0000000000000025 · Cited by 109 · see citing works

New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B

Nurmohamed, N. S., Návar, A. M., & Kastelein, J. J. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.079 · Cited by 110 · see citing works

A new dawn for managing dyslipidemias: The era of rna-based therapies

Macchi, C., Sirtori, C. R., Corsini, A., Santos, R. D., Watts, G. F., & Ruscica, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104413 · Cited by 94 · see citing works

Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol

Georgakis, M. K., Malik, R., Anderson, C. D., Parhofer, K. G., Hopewell, J. C., & Dichgans, M. (2019) · Brain · doi:10.1093/brain/awz413 · Cited by 91 · see citing works

Familial Hypercholesterolemia: Global Burden and Approaches

Tokgözoğlu, L. S., & Kayıkçıoğlu, M. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01565-5 · Cited by 85 · see citing works

Age and sex are associated with the plasma lipidome: findings from the GOLDN study

Slade, E., Irvin, M. R., Xie, K., Arnett, D. K., Claas, S. A., Kind, T., Fardo, D. W., & Graf, G. A. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01456-2 · Cited by 83 · see citing works

The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets

Attaye, I., van Oppenraaij, S. L., Warmbrunn, M. V., & Nieuwdorp, M. (2021) · Nutrients · doi:10.3390/nu14010191 · Cited by 85 · see citing works

An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease

Koren, M. J., Rodriguez, F., East, C., Toth, P. P., Watwe, V., Abbas, C. A., Sarwat, S., Kleeman, K., Kumar, B., Ali, Y., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.03.382 · Cited by 81 · see citing works

Citri Reticulatae Pericarpium (Chenpi): A multi-efficacy pericarp in treating cardiovascular diseases

Zou, J., Wang, J., Ye, W., Lü, J., Li, C., Zhang, D., Ye, W., Xu, S., Chen, C., Liu, P., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113626 · Cited by 78 · see citing works

The association between ambient air pollution and blood lipids: A longitudinal study in Shijiazhuang, China

Zhang, K., Wang, H., He, W., Chen, G., Lu, P., Xu, R., Yu, P., Ye, T., Guo, S., Li, S., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141648 · Cited by 77 · see citing works

Lipid-Modifying Agents, From Statins to PCSK9 Inhibitors

Preiss, D., Tobert, J. A., Hovingh, G. K., & Reith, C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.072 · Cited by 75 · see citing works

Changes in circulating pro-protein convertase subtilisin/kexin type 9 levels – experimental and clinical approaches with lipid-lowering agents

Macchi, C., Banach, M., Corsini, A., Sirtori, C., Ferri, N., & Ruscica, M. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319831500 · Cited by 77 · see citing works

An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia

Koren, M. J., Vega, R. B., Agrawal, N., Xu, Y., Barbour, A., Yu, H., Wallerstedt, E., Carter, D., Middlemiss, J. E., Twaddle, L., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.03.499 · Cited by 76 · see citing works

Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2

Maranta, F., Cianfanelli, L., & Cianflone, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2020_514 · Cited by 69 · see citing works

Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum

Wilkinson, M. J., Lepor, N. E., & Michos, E. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028892 · Cited by 69 · see citing works

Marked plaque regression in homozygous familial hypercholesterolemia

Reeskamp, L. F., Nurmohamed, N. S., Bom, M. J., Planken, R. N., Driessen, R. S., van Diemen, P. A., Luirink, I. K., Groothoff, J. W., Kuipers, I. M., Knaapen, P., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.04.014 · Cited by 68 · see citing works

Recomendaciones para mejorar el control lipídico. Documento de consenso de la Sociedad Española de Cardiología

Escobar, C., Anguita, M. P., Arrarte, V., Barrios, V., Cequier, A. R., Cosı́n-Sales, J., Egocheaga, I., de Sá, E. L., Masana, L., Pallarés‐Carratalá, V., et al. (2019) · Revista Española de Cardiología · doi:10.1016/j.recesp.2019.07.024 · Cited by 63 · see citing works

Garlic: A systematic review of the effects on cardiovascular diseases

Imaizumi, V. M., Laurindo, L. F., Manzan, B., Guiguer, É. L., Oshiiwa, M., Otoboni, A. M. M. B., Araújo, A. C., Tofano, R. J., & Barbalho, S. M. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2043821 · Cited by 65 · see citing works

Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy

Sosnowska, B., Surma, S., & Banach, M. (2022) · Pharmaceuticals · doi:10.3390/ph15121573 · Cited by 62 · see citing works

Systematic Coronary Risk Evaluation (SCORE)

Graham, I. M., Angelantonio, E. D., Visseren, F. L. J., Bacquer, D. D., Ference, B. A., Timmis, A., Halle, M., Vardas, P. E., Huculeci, R., & Cooney, M. T. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.052 · Cited by 60 · see citing works

Changing profiles of cardiovascular disease and risk factors in China: a secondary analysis for the Global Burden of Disease Study 2019

Wang, H., Zhang, H., & Zou, Z. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002741 · Cited by 63 · see citing works

Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices

Thongtang, N., Sukmawan, R., Llanes, E. J. B., & Lee, Z.-V. (2022) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2022.101819 · Cited by 61 · see citing works

Association of four lipid components with mortality, myocardial infarction, and stroke in statin-naive young adults: a nationwide cohort study

Lee, H., Park, J.-B., Hwang, I.-C., Yoon, Y. E., Park, H. E., Choi, S.-Y., Kim, Y.-J., Cho, G.-Y., Han, K., & Kim, H.-K. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319898571 · Cited by 56 · see citing works

Cardiovascular risk and testosterone – from subclinical atherosclerosis to lipoprotein function to heart failure

Gencer, B., Bonomi, M., Adorni, M. P., Sirtori, C. R., Mach, F., & Ruscica, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09628-2 · Cited by 58 · see citing works

ETC-1002 (Bempedoic acid) for the management of hyperlipidemia: from preclinical studies to phase 3 trials

Ruscica, M., Banach, M., Sahebkar, A., Corsini, A., & Sirtori, C. R. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1583209 · Cited by 55 · see citing works

Redox Regulatory Changes of Circadian Rhythm by the Environmental Risk Factors Traffic Noise and Air Pollution

Daiber, A., Frenis, K., Kuntić, M., Li, H., Wolf, E., Kilgallen, A. B., Lecour, S., Laake, L. W. V., Schulz, R., Hahad, O., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0272 · Cited by 54 · see citing works

Public health guidelines should recommend reducing saturated fat consumption as much as possible: NO

Krauss, R. M., & Kris‐Etherton, P. M. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa111 · Cited by 54 · see citing works

Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA)

Rikhi, R. R., Hammoud, A., Ashburn, N. P., Snavely, A. C., Michos, E. D., Chevli, P. A., Tsai, M. Y., Herrington, D. M., & Shapiro, M. D. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.10.004 · Cited by 52 · see citing works

Monomeric C-Reactive Protein in Atherosclerotic Cardiovascular Disease: Advances and Perspectives

Сергеевич, М. И., Kozlov, S. G., Saburova, O., Avtaeva, Y., Guria, K. G., & Ахнафович, Г. З. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032079 · Cited by 51 · see citing works

Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease

Albosta, M. S., Grant, J. K., Taub, P., Blumenthal, R. S., Martin, S. S., & Michos, E. D. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s338424 · Cited by 51 · see citing works

Genetic Risk Stratification

Roberts, R., Chang, C. C., & Hadley, T. D. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.09.004 · Cited by 50 · see citing works

Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study

Abera, A., Worede, A., Hirigo, A. T., Alemayehu, R., & Ambachew, S. (2024) · European journal of medical research · doi:10.1186/s40001-024-01802-x · Cited by 48 · see citing works

The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL

Wu, Z., Huang, Z., Lichtenstein, A. H., Liu, Y., Chen, S., Jin, Y., Na, M., Bao, L., Wu, S., & Gao, X. (2021) · BMC Medicine · doi:10.1186/s12916-021-02014-4 · Cited by 46 · see citing works

Mildly Abnormal Lipid Levels, but Not High Lipid Variability, Are Associated With Increased Risk of Myocardial Infarction and Stroke in “Statin-Naive” Young Population A Nationwide Cohort Study

Park, J., Kim, D. H., Lee, H., Hwang, I., Yoon, Y. E., Park, H. E., Choi, S., Kim, Y.-J., Cho, G., Han, K., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.315705 · Cited by 46 · see citing works

Statin therapy for the primary prevention of cardiovascular disease: Pros

Razavi, A. C., Mehta, A., & Sperling, L. S. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.07.004 · Cited by 44 · see citing works

Risk of Coronary Artery Disease Conferred by Low-Density Lipoprotein Cholesterol Depends on Polygenic Background

Bolli, A., Domenico, P. D., Pastorino, R., Busby, G., & Bottà, G. (2021) · Circulation · doi:10.1161/circulationaha.120.051843 · Cited by 43 · see citing works

Psidium guajava L.: A Systematic Review of the Multifaceted Health Benefits and Economic Importance

Takeda, L. N., Laurindo, L. F., Guiguer, É. L., Bishayee, A., Araújo, A. C., Úbeda, L. C. C., Goulart, R. D. Á., & Barbalho, S. M. (2022) · Food Reviews International · doi:10.1080/87559129.2021.2023819 · Cited by 43 · see citing works

Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden

Zhou, Z., Ong, K. L., Whelton, S. P., Allison, M., Curtis, A. J., Blaha, M. J., Breslin, M. C., Tonkin, A. M., Magnussen, C. G., Budoff, M. J., et al. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.03.025 · Cited by 42 · see citing works

Reduction of Cardio-Metabolic Risk and Body Weight through a Multiphasic Very-Low Calorie Ketogenic Diet Program in Women with Overweight/Obesity: A Study in a Real-World Setting

Tragni, E., Vigna, L., Ruscica, M., Macchi, C., Casula, M., Santelia, A., Catapano, A. L., & Magni, P. (2021) · Nutrients · doi:10.3390/nu13061804 · Cited by 41 · see citing works

Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent

Hao, D., Danbin, W., Maojuan, G., Chun, S., Bin, L., Yang, L., Yingxin, S., Guanwei, F., Chen, Y., Gao, Q., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104306 · Cited by 40 · see citing works

PCSK9 Inhibition and Risk of Diabetes: Should We Worry?

Carugo, S., Sirtori, C. R., Corsini, A., Tokgözoğlu, L. S., & Ruscica, M. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01074-y · Cited by 39 · see citing works

Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis

Marquina, C., Lacaze, P. A., Tiller, J. M., Riaz, M., Sturm, A. C., Nelson, M. R., Ference, B. A., Pang, J., Watts, G. F., Nicholls, S. J., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab770 · Cited by 39 · see citing works

Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR−/− Mice

Zhang, Y., Du, M., Wang, J., & Liu, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.828161 · Cited by 38 · see citing works

Redefining cardiovascular risk prediction: is the crystal ball clearer now?

Tokgözoğlu, L. S., & Torp-Pedersen, C. T. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab310 · Cited by 37 · see citing works

Modulatory role of gut microbiota in cholesterol and glucose metabolism: Potential implications for atherosclerotic cardiovascular disease

Roessler, J., Leistner, D. M., Landmesser, U., & Haghikia, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.018 · Cited by 37 · see citing works

Harnessing RNA Interference for Cholesterol Lowering: The Bench‐to‐Bedside Story of Inclisiran

Wilkinson, M. J., Bajaj, A., Brousseau, M. E., & Taub, P. R. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032031 · Cited by 37 · see citing works

Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies

Malick, W. A., Waksman, O., Do, R., Köenig, W., Pradhan, A. D., Stroes, E. S. G., & Rosenson, R. S. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.02.034 · Cited by 36 · see citing works

Significance of lipids, lipoproteins, and apolipoproteins during the first 14–16 months of life

Nielsen, S. T., Lytsen, R. M., Strandkjær, N., Rasmussen, I. J., Sillesen, A., Vøgg, R. O. B., Raja, A. A., Nordestgaard, B. G., Kamstrup, P. R., Iversen, K. K., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad547 · Cited by 36 · see citing works

Sex Differences in Familial Hypercholesterolemia

Klevmoen, M., Mulder, J. W. C. M., van Lennep, J. E. R., & Holven, K. B. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01155-6 · Cited by 38 · see citing works

A unified framework identifies new links between plasma lipids and diseases from electronic medical records across large-scale cohorts

Veturi, Y., Lucas, A., Bradford, Y., Hui, D., DUDEK, S. M., Theusch, E., Verma, A., Miller, J. E., Kullo, I. J., Hakonarson, H. H., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00879-y · Cited by 35 · see citing works

Cardiovascular Risk Estimation and Stratification Among Individuals with Hypercholesterolemia

Bosco, G., Mszar, R., Piro, S., Sabouret, P. F., & Gallo, A. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01225-3 · Cited by 39 · see citing works

2022 Taiwan lipid guidelines for primary prevention

Huang, P., Lu, Y., Tsai, Y., Wu, Y., Li, H., Chang, H.-Y., Wu, C., Yang, C., Tarng, D., Huang, C., et al. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.05.010 · Cited by 36 · see citing works

Lipoprotein(a): is it more, less or equal to LDL as a causal factor for cardiovascular disease and mortality?

Langsted, A., & Nordestgaard, B. (2020) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000681 · Cited by 25 · see citing works

Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019

Bilitou, A., Were, J., Farrer, A., Rabe, A., Ming, S. W. Y., Haq, I., & Dunton, K. (2022) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s347085 · Cited by 33 · see citing works

Effects of individual and integrated cumulative burden of blood pressure, glucose, low-density lipoprotein cholesterol, and C-reactive protein on cardiovascular risk

Chen, Z., Mo, J., Xu, J., Wang, A., Dai, L., Cheng, A., Yalkun, G., Meng, X., Zhao, X., Li, H., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa052 · Cited by 32 · see citing works

The Cardiac Lipidome in Models of Cardiovascular Disease

Tomczyk, M. M., & Dolinsky, V. W. (2020) · Metabolites · doi:10.3390/metabo10060254 · Cited by 33 · see citing works

Plant Stanol Esters Reduce LDL (Low-Density Lipoprotein) Aggregation by Altering LDL Surface Lipids

Ruuth, M. K., Äikäs, L., Tigistu‐Sahle, F., Käkelä, R., Lindholm, H. J., Simonen, P. P., Kovanen, P. T., Gylling, H., & Öörni, K. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314329 · Cited by 32 · see citing works

Cumulative burden of lipid profiles predict future incidence of ischaemic stroke and residual risk

Dai, L., Xu, J., Zhang, Y., Wang, A., Chen, Z., Mo, J., Li, H., Meng, X., Wu, S., & Wang, Y. (2021) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000726 · Cited by 32 · see citing works

The hemoglobin glycation index predicts the risk of adverse cardiovascular events in coronary heart disease patients with type 2 diabetes mellitus

Xu, S., Qin, Z., Yuan, R., Cui, X., Zhang, L., Bai, J., Liu, G., Wang, Z., Yu, F., Lv, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.992252 · Cited by 31 · see citing works

Dietary fat quality, plasma atherogenic lipoproteins, and atherosclerotic cardiovascular disease: An overview of the rationale for dietary recommendations for fat intake

Christensen, J. J., Arnesen, E., Rundblad, A., Telle‐Hansen, V. H., Narverud, I., Blomhoff, R., Bogsrud, M. P., Retterstøl, K., Ulven, S. M., & Holven, K. B. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117433 · Cited by 31 · see citing works

Novel associations between parental and newborn cord blood metabolic profiles in the Norwegian Mother, Father and Child Cohort Study

Øyri, L. K. L., Bogsrud, M. P., Christensen, J. J., Ulven, S. M., Brantsæter, A. L., Retterstøl, K., Brekke, H. K., Michelsen, T. M., Henriksen, T., van Lennep, J. E. R., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01959-w · Cited by 31 · see citing works

Salvianolic acid B attenuates the inflammatory response in atherosclerosis by regulating MAPKs/ NF-κB signaling pathways in LDLR-/- mice and RAW264.7 cells

Zhang, Y., Feng, X., Du, M., Ding, J., & Liu, P. (2022) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320221079468 · Cited by 31 · see citing works

Selenium-Enriched Cardamine violifolia Increases Selenium and Decreases Cholesterol Concentrations in Liver and Pectoral Muscle of Broilers

Zhao, L., Chu, X.-H., Liu, S., Li, R., Zhu, Y., Li, F.-N., Jiang, J., Zhou, J., Lei, X. G., & Sun, L. (2022) · Journal of Nutrition · doi:10.1093/jn/nxac141 · Cited by 31 · see citing works

Efficacy and Safety of Inclisiran in Asian Patients

Huo, Y., Lesogor, A., Lee, C. W., Chiang, C.-E., Mena-Madrazo, J., Poh, K. K., Jeong, M. H., Maheux, P., Zhang, M., Wei, S., et al. (2024) · JACC: Asia · doi:10.1016/j.jacasi.2023.09.006 · Cited by 31 · see citing works

Avoiding holiday seasonal weight gain with nutrient-supported intermittent energy restriction: a pilot study

Hirsh, S. P., Pons, M., Joyal, S. V., & Swick, A. G. (2019) · Journal of Nutritional Science · doi:10.1017/jns.2019.8 · Cited by 30 · see citing works

Effects of Lipoproteins on Metabolic Health

Albitar, O., D’Souza, C. M., & Adeghate, E. A. (2024) · Nutrients · doi:10.3390/nu16132156 · Cited by 37 · see citing works

The associations between exercise and lipid biomarkers

Sulague, R. M., Suan, N. M., Mendoza, M. F., & Lavie, C. J. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.11.004 · Cited by 30 · see citing works

Evaluations of metabolic and innate immunity profiles in subjects with familial hypercholesterolemia with or without subclinical atherosclerosis

Bosco, G., Barbagallo, F. D. G., Marco, M. D., Scilletta, S., Miano, N., Capuccio, S., Musmeci, M., Mauro, S. D., Filippello, A., Scamporrino, A., et al. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.12.002 · Cited by 28 · see citing works

Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease

Lee, Y., Lee, S. J., Kim, J. W., Lee, S., Kim, G.-S., Park, J. H., Cho, J., Kang, W. C., Yoon, H., Kim, W., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2600283 · Cited by 29 · see citing works

Impact of diet on ten-year absolute cardiovascular risk in a prospective cohort of 94 321 individuals: A tool for implementation of healthy diets

Kjeldsen, E. W., Thomassen, J. Q., Rasmussen, K. L., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Frikke‐Schmidt, R. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100419 · Cited by 28 · see citing works

Lipid-lowering Therapy and Coronary Plaque Regression

Ueki, Y., Itagaki, T., & Kuwahara, K. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv22024 · Cited by 28 · see citing works

The Impact of Dietary Glycemic Index and Glycemic Load on Postprandial Lipid Kinetics, Dyslipidemia and Cardiovascular Risk

Lambadiari, V., Korakas, E., & Tsimihodimos, V. (2020) · Nutrients · doi:10.3390/nu12082204 · Cited by 27 · see citing works

Evaluation of Tannin Extracts, Leonardite and Tributyrin Supplementation on Diarrhoea Incidence and Gut Microbiota of Weaned Piglets

Dell’Anno, M., Reggi, S., Caprarulo, V., Hejna, M., Rossi, C. A. S., Callegari, M. L., Baldi, A., & Rossi, L. (2021) · Animals · doi:10.3390/ani11061693 · Cited by 27 · see citing works

Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland

Björnsson, E., Þorgeirsson, G., Helgadóttir, A., Þorleifsson, G., Sveinbjörnsson, G., Kristmundsdóttir, S., Jónsson, H., Jónasdóttir, A., Jónasdóttir, Á., Sigurðsson, Á., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315904 · Cited by 27 · see citing works

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease

Belch, J. J. F., Brodmann, M., Baumgärtner, I., Binder, C. J., Casula, M., Heiß, C., Kahan, T., Parini, P., Poredoš, P., Catapano, A. L., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.09.022 · Cited by 26 · see citing works

LDL-cholesterol control in the primary prevention of cardiovascular diseases: An expert opinion for clinicians and health professionals

Poli, A., Catapano, A. L., Corsini, A., Manzato, E., Werba, J. P., Catena, G., Cetin, I., Cicero, A. F. G., Cignarella, A., Colivicchi, F., et al. (2022) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2022.10.001 · Cited by 27 · see citing works

Reprint of: Impact of Lipids on Cardiovascular Health

Ference, B. A., Graham, I. M., Tokgözoğlu, L. S., & Catapano, A. L. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.021 · Cited by 26 · see citing works

Management of dyslipidemia in diabetic patients: More than atheroma – The key things to understand in order to avoid a bittersweet taste

Silva, A. M. E. (2021) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.10.005

The burden of cholesterol accumulation through the lifespan: why pharmacological intervention should start earlier to go further?

Zambon, A., Silva, A. M. E., & Farnier, M. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa123 · Cited by 13 · see citing works

Optimization of lipids for prevention in patients with documented atherosclerotic cardiovascular diseases - Our experiences

Burazor, I., Cosic, Z., Babić, R., Otašević, P., Tasic, N., Kostic, S., Bojic, M., Kanjuh, V., & Giga, V. L. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.06.899 · Cited by 1 · see citing works

85: Cardiovascular prevention: A call-to-action to reduce disease burden

(2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.08.087